Involvement of NF-κB in the response of embryonic cells to Methotrexate

Reproductive Toxicology

Volumn 22, Issue 3, 2006, Pages 469-478

  Brengauz Breitmann, Masha ^a   Friedman, Elena ^a   Savion, Shoshana ^a   Torchinsky, Arkady ^a   Fein, Amos ^a   Toder, Vladimir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Apoptosis; Bax; I B ; MEFs; MTX; NF B; Teratogens

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHOTREXATE; PROTEIN BAX; SYNAPTOTAGMIN; ANTINEOPLASTIC ANTIMETABOLITE; APOPTOSIS REGULATORY PROTEIN; BAX PROTEIN, MOUSE; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; RELA PROTEIN, MOUSE; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG SENSITIVITY; EMBRYO; EMBRYO CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ANIMAL; CELL LINE; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; METABOLISM; MOUSE MUTANT; NICK END LABELING; WESTERN BLOTTING;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; FIBROBLASTS; I-KAPPA B PROTEINS; IN SITU NICK-END LABELING; METHOTREXATE; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; NF-KAPPA B; TRANSCRIPTION FACTOR RELA;

EID: 33748423065     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2005.12.010     Document Type: Article

References (54)

1. Gilmore T.D. The Rel/NF-kB signal transduction pathway: introduction. Oncogene 18 (1999) 6842-6844
2. Grilli M., Goffi F., Memo M., and Spano P.F. Interleukin-1β and glutamate activate Rel/NF-kB binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J Biol Chem 271 (1996) 15002-15007
3. Wu M., Lee H., Bellas R.E., Schauer S.L., Arsura M., Katz D., et al. Inhibition of NF-kappaB/Rel induces apoptosis of murine B Cells. EMBO J 15 (1996) 4682-4690
4. Jacobson M.D., Weil M., and Raff M.C. Programmed cell death in animal development. Cell 88 (1997) 347354
5. Sadler T.W., and Hunter E.S. Principles of abnormal development: past, present and future. In: Kimmel C.A., and Beulke-Sam J. (Eds). Developmental toxicology (1994), Raven Press, New York 5363
6. Knudsen T.V. Cell death. In: Kavlock R.J., and Daston G.P. (Eds). Drug toxicity in embryonic development I (1997), Springer-Verlag, Berlin, Heidelberg 211-244
7. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., and Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappaB. Nature 376 (1995) 167-170
8. Beg A.A., and Baltimore D. An essential role for NF-κB in preventing TNF-α induced cell death. Science 274 (1996) 782-784
9. Torchinsky A., Savion S., Gorivodsky M., Shepshelovich J., Zaslavsky Z., Fein A., et al. Cyclophosphamide-induced teratogenesis in ICR mice: the role of apoptosis. Teratogen Carcinogen Mutagen 15 (1995) 179-190
10. Yitzhakie D., Torchinsky A., Savion S., and Toder V. Maternal immunopotentiation affects the teratogenic response to hyperthermia. J Reprod Immunol 45 (1999) 49-66
11. Beekhuijzen M.E., Verhoef A., Klaassen R., Rompelberg C.J., and Piersma A.H. Comparison of in vitro and in vivo developmental toxicity and pharmacokinetics of phenytoin in the rat. Pharmacol Toxicol 87 (2000) 96-102
12. Huang F.J., Shen C.C., Chang S.Y., Wu T.C., and Hsuuw Y.D. Retinoic acid decreases the viability of mouse blastocysts in vitro. Hum Reprod 18 (2003) 130-136
13. Torchinsky A., Brokhman I., Shepshelovich J., Orenstein H., Savion S., Zaslavsky Z., et al. Increased TNF-α expression in cultured mouse embryos exposed to teratogenic concentrations of glucose. Reproduction 125 (2003) 527-534
14. Torchinsky A., Lishanski L., Wolstein O., Shepshelovich J., Orenstein H., Savion S., et al. NF-kappaB DNA-binding activity in embryos responding to a teratogen, cyclophosphamide. BMC Dev Biol 2 (2002) 2-12
15. Acquaah-Mensah G.K., Kehrer J.P., and Leslie S.W. In utero ethanol suppresses cerebellar activator protein-1 and nuclear factor-kappa B transcriptional activation in a rat fetal alcohol syndrome model. J Pharmacol Exp Ther 301 (2002) 277-283
16. Hansen J.M., Gong S.G., Philbert M., and Harris C. Misregulation of gene expression in the redox-sensitive NF-kappab-dependent limb outgrowth pathway by thalidomide. Dev Dyn 225 (2002) 186-194
17. Molestina R.E., Payne T.M., Coppens I., and Sinai A.P. Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane. J Cell Sci 116 (2003) 4359-4371
18. Huennekens F.M. The methotrexate story: a paradigm for development of cancer chemoterapeutic agents. Adv Enzyme Regul 34 (1994) 397-419
19. Lloyd M.E., Carr M., McElhatton P., Hall G.M., and Hughes R.A. The effect of methotrexate on pregnancy, fertility and lactation. QJM 92 (1999) 551-563
20. Donnenfeld A.E., Pastuszak A., Noah J.S., Schick B., Rose N.C., and Koren G. Methotrexate exposure prior and during pregnancy. Teratology 49 (1994) 79-81
21. Sutton C., McIvor R.S., Vagt M., Doggett B., and Kapur R.P. Methotrexate-resistant form of dihydrofolate reductase protects transgenic murine embryos from teratogenic effect of methotrexate. Pediatr Dev Pathol 1 (1998) 503-512
22. Jordan R.L., Wilson J.G., and Schumacher H.J. Embryotoxicity of the folate antagonist methotrexate in rats and rabbits. Teratology 15 (1977) 73-80
23. van den Eijnde S.M., Luijsterburg A.J., Boshart L., De Zeeuw C.I., van Dierendonck J.H., Reutelingsperger C.P., et al. In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. Cytometry 9 (1997) 313-320
24. Sankar G., Michael J.M., and Kopp B.E. NF-κB and rel proteins: evolutionarily conserved mediators of immune responses. Ann Rev Immunol 16 (1998) 225-260
25. Huschtscha L.I., Bartier W.A., Anderson Ross C.E., and Tattersall M.H.N. Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br J Cancer 73 (1996) 54-60
26. Chow M., and Rubin H. Ubiquitous heritable damage in cell populations that survive treatment with methotrexate. Proc Natl Acad Sci USA 94 (1997) 8773-8778
27. Papaconstantinou H.T., Xie C., Zhang W., Ansari N.H., Hellmich M.R., Townsend C., et al. The role of caspases in methotrexate-induced gastrointestinal toxicity. Surgery 130 (2001) 859-865
28. Li M., Shillinglaw W., Henzel W.J., and Beg A.A. The Rela (p65) subunit of NF-kappaB is essential for inhibiting double-stranded RNA-induced cytotoxicity. J Biol Chem 276 (2001) 1185-1194
29. Curry H.A., Clemens R.A., Shah S., Bradbury C.M., Botero A., Goswami P., et al. Heat shock inhibits radiation-induced activation of NF-kappaB via inhibition of I-kappaB kinase. J Biol Chem 274 (1999) 23061-23067
30. Wang Z., Castresana M.R., Detmer K., and Newman W.H. An IkB-α mutant inhibits cytokine gene expression and proliferation in human vascular smooth muscle cells. J Surg Res 102 (2002) 198-206
31. Heenen M., Laporte M., Noel J.C., and de Graef C. Methotrexate induces apoptotic cell death in human keratinocytes. Arch Dermatol Res 290 (1998) 240-245
32. Bharti A.C., Donato N., Singh S., and Aggarwal B.B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappaB and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101 (2003) 1053-1062
33. Merkle C.J., Moore I.M., Penton B.S., Torres B.J., Cueny R.K., Schaeffer R.C., et al. Methotrexate causes apoptosis in postmitotic endothelial cells. Biol Res Nurs 2 (2000) 5-14
34. Quemeneur L., Gerald L.M., Flacher M., French M., Revillard J.P., and Genestier L. Differential control of cell cycle, proliferation, and survival of primary T lymphocyes by purine and pyrimidine nucleotides. J Immunol 170 (2003) 4986-4995
35. Autieri M.V., Yue T.L., Ferstein G.Z., and Ohlstein E. Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Biochem Biophys Res Commun 213 (1995) 827-836
36. Logvinova A.V., Foehr M.W., Pemberton P.A., Khazalpour K.M., Funk-Archuleta M.A., Bathurst I.C., et al. Soy-derived antiapoptotic fractions protect gastrointestinal epithelium from damage caused by methotrexate treatment in the rat. Nutr Cancer 33 (1999) 33-39
37. Nakazawa F., Matsuno H., Yudoh K., Katayama R., Sawai T., Uzuki M., et al. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J Rheumatol 28 (2001) 1800-1808
38. Strauss G., Osen W., and Debatkin K.M. Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs. Clin Exp Immunol 128 (2002) 255-266
39. Starenki D., Namba H., Saenko V., Ohtsuri A., and Yamashita S. Inhibition of nuclear factor-kB cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells. J Clin Endocrinol Metab 89 (2004) 410-418
40. Cory S., and Adams J.M. The bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2 (2002) 647-656
41. Sun F., Akazawa S., Sugahara K., Kamihira S., Kawasaki E., and Eguchi K. Apoptosis in normal rat embryo tissues during early organogenesis: the possible involvement of Bax and bcl-2. Arch Histol Cytol 65 (2002) 145-157
42. Mammon K, Savion S, Keshet R, Orenstein H, Fein A, Torchinsky A, et al. Expression of apoptosis-associated molecules in the fetoplacental unit of teratogen-treated mice. Reproduction, submitted for publication.
43. Chen H.W., Jiang W.S., and Tzeng C.R. Nitric oxide as a regulator in preimplantation embryo development and apoptosis. Fertil Steril 75 (2001) 1163-1171
44. Fernandez E.L., Gustafson A.L., Andersson M., Hellman B., and Dencker L. Cadmium-induced changes in apoptotic gene expression levels and DNA damage in mouse embryos are blocked by zinc. Toxicol Sci 76 (2003) 162-170
45. Korhonen L., Belluardo N., Mudo G., and Lindholm D. Increase in bcl-2 phosphorylation and reduced levels of BH3-only bcl-2 family proteins in kainic acid-mediated neuronal death in the rat brain. Eur J Neurosci 18 (2003) 1121-1134
46. Read M., Whitley M.Z., Williams A.J., and Collins T. NF-kB and IkBα: an inducible regulatory system in endothelial activation. J Exp Med 179 (1994) 503-512
47. van't Land B., Blijlevens N.M.A., Marteihn J., Timal S., Donnelly J.P., de Witte T.J.M., et al. Role of curcumin and the inhibitor of NF-kB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia 18 (2004) 276-284
48. LeBail O., Schmidtullrich R., and Israël A. Promoter analysis of the gene encoding the IkBα/mad3 inhibitor of NF-kB: positive regulation by members of the rel/NF-kB family. EMBO J 12 (1993) 5043-5049
49. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-kB controls expression of inhibitor IkBα: evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
50. Chiao P.J., Miaomoto S., and Verna I.M. Autoregulation of IkBα activity. Proc Natl Acad Sci USA 91 (1994) 28-32
51. Ito C., Kazantsev A.G., and Baldwin Jr. A.S. Three NF-kB sites in the IkB-α promoter are required for induction of gene expression by TNF-α. Nucleic Acids Res 22 (1994) 3787-3792
52. Arenzana-Seisdedos F., Turpin P., Rodriguez M., Thomas D., Hay R.T., Virelizier J.L., et al. Nuclear localization of I kappa B alpha promotes qctive transport of NF kappa B from the nucleus to the cytoplasm. J Cell Sci 110 (1997) 369-378
53. Beg A.A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., and Baldwin Jr. A.S. IkappaB interacts with the nuclear localization sequences of the subunits of NF-kappaB: a mechanism for cytoplasmatic retention. Genes Dev 6 (1992) 1899-1913
54. Hoffmann A., Leung T.H., and Baltimore D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J 22 (2003) 5530-5539